Funding for this research was provided by:
North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill (550KR161723)
Text and Data Mining valid from 2019-03-13
Received: 6 April 2018
Accepted: 6 March 2019
First Online: 13 March 2019
Ethics approval and consent to participate
: The University of North Carolina Institutional Review Board (IRB) approved this study (#17–0287) and deemed it a non-significant risk medical device study with a waiver of written (signed) consent for initial consent only to be followed by signed consent upon hospital arrival. Consent from participants will be obtained with approved recruitment script and consent form.
: Not applicable. This manuscript does not contain data from any individual person.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.